Skip to main content
OpenTrials
Completed

NCT Number: NCT00229385

Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)

Comparing schizophrenic patients with comorbid OCD and schizophrenic patients without OCD in response to Ziprasidone and in cognitive functioning as compared with OCD patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Anxiety Disorders Mental Disorders Obsessive Compulsive Disorder Obsessive-Compulsive Disorder Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chaim Sheba Medical Center

Ramat Gan, 52621, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of Schizophrenia and OCD for at least 6 months
  • Minimum score of 14 on YBOCS
  • Minimum score of 60 on PANSS
  • Diagnosis of Schizophrenia without OC symptoms

Exclusion criteria

  • Patients who are already being treated with ziprasidone
  • Diagnosis of schizophreniform disorder
  • Organic brain syndrome, mental retardation and pervasive developmental disorder
  • Patients having any significantly cardiovascular illness or electrolyte imbalance

Treatment and study plan

Ziprasidone

Drug

40-80 mg BID

Primary outcomes

  1. YBOCS

    Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Sheba Medical Center

Other Gov

Registry information

Important dates

Study start
2006
Primary completion
2008
Study completion
2010
First posted
Sep 29, 2005
Registry last updated
Dec 31, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.